These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8646071)
41. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Price VE; Dutta S; Blanchette VS; Butchart S; Kirby M; Langer JC; Ford-Jones EL Pediatr Blood Cancer; 2006 May; 46(5):597-603. PubMed ID: 16333816 [TBL] [Abstract][Full Text] [Related]
42. [Pneumococcal vaccination after splenectomy]. Ejstrud P Ugeskr Laeger; 1996 Dec; 158(51):7430-1. PubMed ID: 9012066 [No Abstract] [Full Text] [Related]
43. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Meerveld-Eggink A; de Weerdt O; Rijkers GT; van Velzen-Blad H; Biesma DH Vaccine; 2008 Dec; 26(52):6975-9. PubMed ID: 18848594 [TBL] [Abstract][Full Text] [Related]
44. [Decreased penicillin sensitivity of pneumococci]. Zbinden R Ther Umsch; 1998 Jan; 55(1):18-21. PubMed ID: 9492613 [TBL] [Abstract][Full Text] [Related]
45. [Post-splenectomy infections and Pneumococcus vaccination in paediatric surgery (author's transl)]. Belohradsky BH; Däumling S; Roos R; Holschneider AM; Griscelli C Z Kinderchir; 1982 Apr; 35(4):140-4. PubMed ID: 7102107 [TBL] [Abstract][Full Text] [Related]
46. Survey of penicillin resistant pneumococci at Kenyatta National Hospital, Nairobi. Ndinya-Achola JO; Omari MA; Odhiambo FA; Murage E; Mutere AN East Afr Med J; 1997 Mar; 74(3):151-3. PubMed ID: 9185410 [TBL] [Abstract][Full Text] [Related]
47. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Davies JM; Lewis MP; Wimperis J; Rafi I; Ladhani S; Bolton-Maggs PH; Br J Haematol; 2011 Nov; 155(3):308-17. PubMed ID: 21988145 [TBL] [Abstract][Full Text] [Related]
48. Protecting asplenic individuals from fulminant pneumococcal disease. Nohynek H Euro Surveill; 2010 Jun; 15(23):. PubMed ID: 20546696 [No Abstract] [Full Text] [Related]
49. Infectious complications in asplenic hosts. Sumaraju V; Smith LG; Smith SM Infect Dis Clin North Am; 2001 Jun; 15(2):551-65, x. PubMed ID: 11447709 [TBL] [Abstract][Full Text] [Related]
50. [DRUG-RESISTANCE PATTERNS OF PNEUMOCOCCI AND EPIDEMIOLOGIC AND GENETIC PROBLEMS]. ICHIHASHI Y J Antibiot B; 1964 Jun; 17():116-9. PubMed ID: 14201523 [No Abstract] [Full Text] [Related]
51. [Development of antibiotic resistance of Pneumococcus. A new way for prescribing antibiotics in pediatrics]. Cohen R; Reinert P; Geslin P Arch Fr Pediatr; 1992 Feb; 49(2):77-9. PubMed ID: 1580741 [No Abstract] [Full Text] [Related]
52. [A handling program for resistant pneumococci. Physicians sometimes neglect mandatory notification]. Hedlund J; Olsson-Liljequist B Lakartidningen; 1997 Dec; 94(51-52):4914-8. PubMed ID: 9454013 [TBL] [Abstract][Full Text] [Related]
55. [Prevention of severe infections in patients with hyposplenism or asplenia]. Lammers AJ; van der Maas N; Peters EJ; Meerveld-Eggink A; Sanders EA; Kroon FP; Ned Tijdschr Geneeskd; 2012; 156(44):A4857. PubMed ID: 23114171 [TBL] [Abstract][Full Text] [Related]
56. [Vaccination after splenectomy]. Abrahamsen AF Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3118. PubMed ID: 7974438 [No Abstract] [Full Text] [Related]